These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13030395)

  • 21. Complete heart block with Adams-Stokes seizures from ventricular fibrillation. Recovery after treatment with repeated external electrical defibrillation.
    SACOLICK SL; STEIN WG; FRIEDBERG CK
    Arch Intern Med; 1962 Sep; 110():299-304. PubMed ID: 14495877
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR; Kelly RJ; Kovacs JL
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOXICITY OF QUINIDINE.
    BRENNER O; DAVISON PH; EVANS DW
    Lancet; 1964 Nov; 2(7370):1184. PubMed ID: 14213600
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of quinidine on ventricular fibrillation induced by coronary ligation.
    LEADT JR; ALLEN JB
    Am Heart J; 1950 Feb; 39(2):279-82. PubMed ID: 15402091
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
    Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression of the heart by quinidine and its treatment.
    FINNEGAN TR; TROUNCE JR
    Br Heart J; 1954 Oct; 16(4):341-50. PubMed ID: 13208892
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacology of chronic ventricular fibrillation].
    KOSZEGVARY S
    Orv Hetil; 1953 Feb; 94(5):130-2. PubMed ID: 13055255
    [No Abstract]   [Full Text] [Related]  

  • 29. ATRIAL FLUTTER-FIBRILLATION WITH A-V BLOCK TERMINATED BY EXTERNAL COUNTERSHOCK.
    RUTLEDGE DI; ZOLL PM
    Lahey Clin Found Bull; 1963; 13():76-7. PubMed ID: 14078128
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of quinidine and digitalis on the incidence of ventricular fibrillation after direct current discharges in the dog.
    Scheinin TM; Kallio V; Linna MI
    Ann Med Exp Biol Fenn; 1967; 45(4):384-8. PubMed ID: 5599051
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of high doses of quinidine on ventricular tachycardia and contractility of the dog heart in chronic oral administration].
    DOERNER J; WICK E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():97-8. PubMed ID: 13817204
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of antifibrillatory drugs on the cat's heart in vivo.
    JOHNSON EA
    Br J Pharmacol Chemother; 1954 Sep; 9(3):341-5. PubMed ID: 13199254
    [No Abstract]   [Full Text] [Related]  

  • 33. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of quinidine and propranolol on vulnerability of the ventricle to electrical fibrillation.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):231-41. PubMed ID: 4827411
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of quinidine and propranolol in experimental cardiac arrhythmias in the dog.
    Madan BR; Pendse VK
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):287-93. PubMed ID: 849075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventricular fibrillation threshold in canine hearts with quinidine induced prolonged QT interval: effects of atrial pacing, isoproterenol, and lignocaine.
    Inoue H; Matsuo H; Mashima S; Sugimoto T; Murao S
    Cardiovasc Res; 1986 May; 20(5):349-57. PubMed ID: 3756976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nature of [Ca2+]i transients during ventricular fibrillation and quinidine treatment in perfused rat hearts.
    Kojima S; Wikman-Coffelt J; Wu ST; Parmley WW
    Am J Physiol; 1994 Apr; 266(4 Pt 2):H1473-84. PubMed ID: 8184925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quinidine poisoning].
    Exaire S; Cárdenas M; Rotberg T
    Arch Inst Cardiol Mex; 1967; 37(3):321-9. PubMed ID: 6057343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.